The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker

<p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Purpose:</strong> To study the effects of...

Full description

Bibliographic Details
Main Author: Hayat Mombini
Format: Article
Language:English
Published: Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences 2004-06-01
Series:Urology Journal
Online Access:http://www.urologyjournal.org/index.php/uj/article/view/341/335
_version_ 1819035189967323136
author Hayat Mombini
author_facet Hayat Mombini
author_sort Hayat Mombini
collection DOAJ
description <p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Purpose:</strong> To study the effects of Tamsulosine (Flowmax) as a specific ?-blocker in patients with prostate weighted less than 40 g and lacked median lobe and to compare them to patients with prostate weighted more than 40 g with median lobe.</span></span></p><p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Materials and Methods:</strong> Forty outpatients with BPH were referred to clinic and intentionally enrolled in this study. Patients were divided into 2 groups of 20 patients. Tamsulosine was daily administered for all of them for 6 weeks. Routine tests were performed for all patients, all of which were normal. The probability of prostate cancer was ruled out. The size of prostate and type of hypertrophy were determined by one radiologist via DRE, suprapubic ultrasonography and TRUS-P. Patients were divided into A and B groups according to the size of prostate and the lack of median lobe or its presence. Prostate size was less than 40 mg in group A and all patients lacked median lobe; whereas, prostate size was more than 40 mg (between 40-60 mg) in group B and patients had some median lobe.</span></span></p><p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Results:</strong> An increase of 30% in base line Q Max and a decrease of 25% in base line IPSS was seen in 16 patients (80%) of group A, while these were observed only 9 patients (45%) of group B. </span></span></p><p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Conclusion:</strong> Determination of prostate size and the type of hypertrophy seems to be essential before any Tamsulosine administration. The weight of prostate is determined by protoscan.</span></span></p>
first_indexed 2024-12-21T07:45:41Z
format Article
id doaj.art-ef8634fe87a843038ba1551d5f3fa2bb
institution Directory Open Access Journal
issn 1735-1308
1735-546X
language English
last_indexed 2024-12-21T07:45:41Z
publishDate 2004-06-01
publisher Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
record_format Article
series Urology Journal
spelling doaj.art-ef8634fe87a843038ba1551d5f3fa2bb2022-12-21T19:11:13ZengUrology and Nephrology Research Center, Shahid Beheshti University of Medical SciencesUrology Journal1735-13081735-546X2004-06-0112115116The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-BlockerHayat Mombini<p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Purpose:</strong> To study the effects of Tamsulosine (Flowmax) as a specific ?-blocker in patients with prostate weighted less than 40 g and lacked median lobe and to compare them to patients with prostate weighted more than 40 g with median lobe.</span></span></p><p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Materials and Methods:</strong> Forty outpatients with BPH were referred to clinic and intentionally enrolled in this study. Patients were divided into 2 groups of 20 patients. Tamsulosine was daily administered for all of them for 6 weeks. Routine tests were performed for all patients, all of which were normal. The probability of prostate cancer was ruled out. The size of prostate and type of hypertrophy were determined by one radiologist via DRE, suprapubic ultrasonography and TRUS-P. Patients were divided into A and B groups according to the size of prostate and the lack of median lobe or its presence. Prostate size was less than 40 mg in group A and all patients lacked median lobe; whereas, prostate size was more than 40 mg (between 40-60 mg) in group B and patients had some median lobe.</span></span></p><p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Results:</strong> An increase of 30% in base line Q Max and a decrease of 25% in base line IPSS was seen in 16 patients (80%) of group A, while these were observed only 9 patients (45%) of group B. </span></span></p><p class="MsoNormal" style="margin: 0cm 0cm 0pt; direction: ltr; unicode-bidi: embed; text-align: left;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong>Conclusion:</strong> Determination of prostate size and the type of hypertrophy seems to be essential before any Tamsulosine administration. The weight of prostate is determined by protoscan.</span></span></p>http://www.urologyjournal.org/index.php/uj/article/view/341/335
spellingShingle Hayat Mombini
The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker
Urology Journal
title The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker
title_full The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker
title_fullStr The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker
title_full_unstemmed The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker
title_short The Relationship between Weight as Well as the Kind of Prostate Hypertrophy and the Response to Tamsulosine, a Specific ?-Blocker
title_sort relationship between weight as well as the kind of prostate hypertrophy and the response to tamsulosine a specific blocker
url http://www.urologyjournal.org/index.php/uj/article/view/341/335
work_keys_str_mv AT hayatmombini therelationshipbetweenweightaswellasthekindofprostatehypertrophyandtheresponsetotamsulosineaspecificblocker
AT hayatmombini relationshipbetweenweightaswellasthekindofprostatehypertrophyandtheresponsetotamsulosineaspecificblocker